235.71USD+0.34%Mkt Cap: 15.13B $P/E: 22.711d ago
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis…
Indicators:|
Key Statistics
Company
Market Cap15.13B $
Enterprise Value28.64B $
Revenue (TTM)13.84B $
Gross Profit4.40B $
Net Income (TTM)746.80M $
Revenue/Share194.22 USD
Last Price235.71 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees78.0K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)22.71
P/E (Forward)12.95
PEG0.67
EV/EBITDA10.26
EV/Revenue2.07
P/S1.03
P/B-19.49
EPS (TTM)10.39
EPS (Forward)17.18
52W Range
101.0098% of range238.64
52W High238.64 USD
52W Low101.00 USD
Profitability
Gross Margin32.25%
Oper. Margin13.86%
EBITDA Margin20.19%
Profit Margin5.47%
ROE-114.70%
ROA4.27%
Growth
Revenue Growth6.00%
Earnings Growth43.50%
Cash Flow & Leverage
Operating CF1.89B $
CapEx (TTM)575.86M $
FCF Margin7.23%
FCF Yield6.61%
Net Debt12.55B $
Net Debt/EBITDA4.50
Balance Sheet
Debt/Equity-19.77
Current Ratio1.42
Quick Ratio1.28
Book Value/Sh-11.4150 USD
Cash/Share10.38 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateSep 9, 2013
Analyst Consensus
Rating—
Target (Mean)193.71 USD
Upside (mean)-17.8%
Target Range145.00 USD – 235.00 USD
$145.00-17.8% to mean$235.00
# Analysts7
Ownership
Shares Out.64.19M
Float34.18M
Insiders50.30%
Institutions52.65%
Short Interest
Short Ratio5.8d
Short % Float14.10%
Short % Out.7.21%
Shares Short4.63M
Short (prev mo.)5.68M
Technical
SMA 50188.09 (+25.3%)
SMA 200144.69 (+62.9%)
Beta0.91
S&P 52W Chg20.05%
Avg Vol (30d)531.12K
Avg Vol (10d)918.42K
Technical Indicators
RSI (14)84.9
MACD10.4274
MACD Signal8.5999
MACD Hist.+1.8275
BB Upper236.14 USD
BB Middle211.78 USD
BB Lower187.41 USD
BB Width23.01%
ATR (14)6.023 USD
Vol Ratio (20d)1.18x